Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification
NCT ID: NCT04069104
Last Updated: 2021-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1849 participants
OBSERVATIONAL
2020-11-13
2021-03-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ABCD training with standard feedback
Asymmetry, Border, Color, Diameter (ABCD) training message intervention with standard dermatological feedback
ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.
Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.
ABCD training with motivational feedback
ABCD training message intervention with dermatological feedback and a motivational message
ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.
Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.
ABCD training with no feedback
ABCD message intervention with no feedback
ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.
UDS method training with standard feedback
Ugly Duckling Sign (UDS) method message intervention with dermatological feedback.
UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.
Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.
UDS method training with motivational feedback
UDS message intervention with dermatological feedback and a motivational message.
UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.
Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.
UDS training with no feedback
UDS message intervention with no feedback.
UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.
ABCD-F training with standard feedback
ABCD-F intervention with dermatological feedback.
ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.
UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.
Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.
ABCD-F training with motivational feedback
ABCD-F intervention with dermatological feedback and a motivational message.
ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.
UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.
Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.
ABCD-F training with no feedback
ABCD-F intervention with no feedback.
ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.
UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.
No message intervention with standard feedback
No message intervention, but with dermatological feedback.
Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.
No message intervention with motivational feedback
No message intervention, but with dermatological feedback and a motivational message.
Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.
No message intervention with no feedback
No message intervention and no feedback. True control.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABCD Information
The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.
UDS information
The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.
Standard (clinical) feedback
Feedback on mole identification task provided by a dermatologist.
Motivational feedback
Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years old
* Capable of reading English
* Member of panel assembled by survey provider
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicholas Carcioppolo
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicholas Carcioppolo, PhD
Role: PRINCIPAL_INVESTIGATOR
Study Co-Principal Investigator
Soyoon Kim, PhD
Role: PRINCIPAL_INVESTIGATOR
Study Co-Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Coral Gables, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20190153
Identifier Type: -
Identifier Source: org_study_id